Pascal Chanez Selected Research

Interleukin-5 (Interleukin 5)

1/2021	Anti-interleukin 5 therapies failure criteria in severe asthma: a Delphi-consensus study.
1/2019	"T2-high" in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin.
10/2017	Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease.
9/2013	Anti-interleukin-5 therapy in severe asthma.
1/2013	Effect of nebulized beclomethasone on airway inflammation and clinical status of children with allergic asthma and rhinitis: a randomized, double-blind, placebo-controlled study.
1/2007	Evaluation and management of severe asthma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pascal Chanez Research Topics

Disease

104	Asthma (Bronchial Asthma) 03/2024 - 03/2002
27	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2004
24	Inflammation (Inflammations) 01/2022 - 06/2002
5	Hypersensitivity (Allergy) 03/2024 - 09/2015
5	Eosinophilia 01/2022 - 10/2016
4	Dyspnea (Shortness of Breath) 01/2019 - 11/2007
3	Airway Remodeling 04/2024 - 08/2009
3	Sinusitis 01/2022 - 01/2021
3	Airway Obstruction (Choking) 01/2021 - 11/2013
3	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021 - 01/2016
3	Rhinitis 01/2013 - 08/2010
2	Rheumatoid Arthritis 11/2023 - 01/2019
2	Lung Diseases (Lung Disease) 11/2023 - 01/2018
2	Headache (Headaches) 01/2022 - 01/2021
2	Fever (Fevers) 01/2022 - 01/2021
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2016
2	Nasopharyngitis 01/2021 - 10/2016
2	Pneumonia (Pneumonitis) 01/2020 - 09/2015
2	Obesity 01/2019 - 01/2015
2	Bronchial Hyperreactivity 01/2019 - 01/2008
2	Cough 01/2017 - 01/2013
2	Respiratory Insufficiency (Respiratory Failure) 11/2016 - 01/2015
2	Overweight 01/2014 - 08/2010
2	Infections 06/2013 - 04/2009
2	Respiratory Sounds (Crackle) 01/2013 - 01/2013
2	Neoplasms (Cancer) 09/2011 - 04/2010
1	Immune System Diseases (Immune Disorders) 11/2023
1	Dermatomyositis (Dermatopolymyositis) 11/2023
1	Dermatitis 07/2023

Drug/Important Bio-Agent (IBA)

42	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2024 - 11/2002
17	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2009
11	Interleukin-8 (Interleukin 8)IBA 01/2023 - 06/2002
10	SteroidsIBA 01/2022 - 11/2003
8	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2024 - 11/2004
8	Immunoglobulin E (IgE)IBA 04/2023 - 01/2007
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2010
8	mepolizumabIBA 01/2021 - 08/2012
8	GlucocorticoidsIBA 10/2017 - 06/2002
7	InterleukinsIBA 04/2024 - 01/2010
7	Monoclonal AntibodiesIBA 01/2021 - 01/2008
6	Omalizumab (Xolair)FDA Link 10/2022 - 01/2008
6	Interleukin-5 (Interleukin 5)IBA 01/2021 - 01/2007
6	Bronchodilator Agents (Bronchodilators)IBA 01/2017 - 01/2007
5	CytokinesIBA 04/2024 - 03/2002
5	benralizumabIBA 07/2023 - 10/2016
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2014 - 03/2002
4	Interleukin-33IBA 04/2024 - 01/2017
4	PeriostinIBA 01/2021 - 06/2015
4	GoldIBA 01/2021 - 01/2007
4	LipoxinsIBA 01/2016 - 06/2002
3	SmokeIBA 01/2022 - 01/2019
3	LeukotrienesIBA 01/2021 - 11/2003
3	EicosanoidsIBA 01/2021 - 06/2002
3	anti-IgE antibodiesIBA 01/2020 - 01/2008
3	Tiotropium Bromide (Spiriva)FDA Link 01/2020 - 03/2014
3	prednylidene (Pred)IBA 01/2019 - 06/2007
3	aclidinium bromideIBA 03/2014 - 02/2011
3	LeptinIBA 09/2011 - 08/2009
2	Interleukin-17 (Interleukin 17)IBA 04/2024 - 01/2013
2	Thymic Stromal LymphopoietinIBA 04/2024 - 01/2017
2	LipidsIBA 01/2023 - 01/2005
2	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 11/2022 - 10/2013
2	ChemokinesIBA 01/2022 - 01/2017
2	LigandsIBA 01/2022 - 01/2017
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2019
2	C-Reactive ProteinIBA 01/2022 - 08/2010
2	Leukotriene E4IBA 01/2021 - 11/2003
2	Interleukin-5 Receptors (Interleukin 5 Receptor)IBA 01/2020 - 10/2016
2	Oxygen (Dioxygen)IBA 01/2020 - 01/2019
2	MacrolidesIBA 01/2020 - 01/2007
2	AntibodiesIBA 01/2019 - 01/2008
2	Interleukin-13IBA 01/2019 - 09/2015
2	MucinsIBA 01/2019 - 05/2012
2	Secretory Immunoglobulin A (SIgA)IBA 11/2018 - 01/2018
2	HLA-G Antigens (HLA G)IBA 01/2018 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2018 - 06/2002
2	EnzymesIBA 01/2018 - 11/2003
2	AllergensIBA 01/2016 - 06/2013
2	lipoxin A4IBA 01/2016 - 06/2002
2	Leukotriene B4IBA 01/2016 - 01/2005
2	CollagenIBA 11/2015 - 01/2004
2	Muscarinic AntagonistsIBA 01/2015 - 04/2011
2	Fluticasone (Cutivate)FDA LinkGeneric 10/2014 - 03/2007
2	Beclomethasone (Beclometasone)FDA Link 10/2013 - 01/2013
2	Formoterol Fumarate (Oxis)FDA Link 10/2013 - 01/2013
2	Methacholine Chloride (Methacholine)FDA Link 01/2013 - 08/2010
2	Leptin ReceptorsIBA 09/2011 - 08/2009
2	NF-kappa B (NF-kB)IBA 12/2009 - 11/2003
2	indacaterolIBA 07/2008 - 01/2007
1	AndrogensIBA 09/2023
1	Anabolic Androgenic SteroidsIBA 09/2023

Therapy/Procedure

22	Therapeutics 04/2024 - 10/2006
10	Bronchial Thermoplasty 01/2019 - 12/2014
3	Biological Therapy 01/2021 - 01/2016
3	Artificial Respiration (Mechanical Ventilation) 01/2020 - 01/2015
2	Noninvasive Ventilation 01/2020 - 01/2017
2	Subcutaneous Injections 10/2017 - 04/2009
2	Aftercare (After-Treatment) 11/2015 - 01/2013
2	Lung Transplantation 06/2013 - 09/2012
1	Breast Implants (Breast Implant) 11/2023